Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.34 |
| ▸ | MERTK | Q12866 | 1/20 | 0.34 |
| ▸ | GAS6 | Q14393 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL714018 | 0.99 | KMT2A (0.43) | KMT2ALMNAFLT3TYRO3MERTK | |
| SCHEMBL698650 | 0.96 | KMT2A (0.40) | KMT2ALMNAFLT3TYRO3MERTK | |
| SCHEMBL9373101 | 0.93 | FLT3 (0.37) | KMT2AFLT3TYRO3MERTKGAS6 | |
| SCHEMBL9645849 | 0.92 | FLT3 (0.35) | KMT2AFLT3TYRO3MERTKGAS6 | |
| SCHEMBL11255263 | 0.87 | FLT3 (0.34) | KMT2AFLT3TYRO3MERTKGAS6 | |
| SCHEMBL2022080 | 0.87 | KMT2A (0.45) | KMT2ALMNANR1I2AHRCA12 | |
| SCHEMBL9428396 | 0.86 | KMT2A (0.42) | KMT2ALMNANR1I2AHR | |
| SCHEMBL27717304 | 0.85 | FLT3 (0.36) | KMT2AFLT3TYRO3MERTKGAS6 | |
| SCHEMBL7458930 | 0.85 | KMT2A (0.40) | KMT2ALMNANR1I2AHRCA12 | |
| SCHEMBL10811647 | 0.83 | KMT2A (0.46) | KMT2ALMNANR1I2AHRCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100074083-A1 | RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100074083-A1 | RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION | SEM1, WDR5, WDR1 | KMT2A 736/4885LMNA 2153/4885FLT3 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.